Standard BioTools

Last updated
Standard BioTools Inc.
Formerly
  • Fluidigm Corporation
  • Mycometrix
Company type Public
Founded1999;26 years ago (1999)
Headquarters,
United States
Key people
Michael Egholm (president & CEO)
RevenueIncrease2.svg US$130.6 million (2021) [1]
Number of employees
615 (December 2021) [2]
Website standardbio.com
Standard BioTools Canada Markham SBI.jpg
Standard BioTools Canada

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), [3] and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

Contents

Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.

Business model

Standard BioTools is a public company traded on the Nasdaq stock exchange, previously under the ticker symbol FLDM, [4] currently under LAB.

Its genomic analysis products create microfluidic devices or IFCs. [5] [6] Genomics applications using IFCs processed on the Biomark™ X9 System for High-Throughput Genomics include gene expression and genotyping by PCR and NGS library preparation for pathogen detection, agrigenomics, sample identification and pharmacogenomics.

Its proteomic analysis products are based on technology developed by DVS Sciences, acquired by Fluidigm® in 2014. [6] DVS is best known for its multiparameter single-cell protein analysis systems, [7] which analyze antibody/metal complexes using atomic mass spectrometry. The technology enables precise, high-parameter single-cell protein analysis for applications in life sciences research.

The company has remained a pioneer in integrated microfluidic technology, with continued iterations of IFCs for a growing variety of applications.[ citation needed ] It is also the only company developing mass cytometry technologies for both flow cytometry and imaging applications.[ citation needed ]

History

The company was founded in 1999 as Mycometrix by Stephen Quake and Gajus Worthington. [8] The company was formed to commercialize technology developed by Quake at the California Institute of Technology referred to as microfluidic large-scale integration and branded IFCs[1]. Richard DeLateur, a 20-year veteran of Intel, came on as chief financial officer in 2006. [9] Worthington was the company’s chief executive officer from its inception in 1999 to 2016. Quake has remained a member of the company’s scientific advisory board.

The company’s founders created integrated circuits that carried fluids rather than electrons. In 2009, the company was described as “the world’s leading manufacturer of microfluidic devices [5] .” The company’s original microfluidics products were aimed for use in applications such as protein crystallization, genotyping, DNA analysis and PCR.

The company completed a successful initial public offering (IPO) in February 2011, raising about $75 million. [4] This followed a failed, ill-timed IPO in 2008. [10] As of the 2011 IPO, Fluidigm had not yet become profitable. Following a $250 million investment from Casdin Capital, LLC and Viking Global Investors LP in April 2022, Fluidigm changed its name to Standard BioTools. [11] This change in name emphasized their mission to create a diversified, scalable innovation-focused life science tools company serving the pharma research markets. [12]

The company acquired Nasdaq-listed SomaLogic in January 2024 in an all-stock deal. [13]

Operations

At the end of 2023, Standard BioTools had a headcount of 500 personnel.

In addition to its headquarters and laboratory facility in South San Francisco, California, which it expanded in 2014, the company established the first biochip manufacturing facility in Singapore in 2005.

In 2022, Standard BioTools expanded their offices and manufacturing and research and development facility in Markham, Ontario.[ citation needed ]

Notes

  1. Linthwaite & Jog 2022, p. 75.
  2. Linthwaite & Jog 2022, p. 15.
  3. Dutton, Gail (2015-01-14). "Fluidigm Pioneers Single-Cell Biology". GEN - Genetic Engineering and Biotechnology News. Retrieved 2023-12-11.
  4. 1 2 Tse, Andrea (2011-02-10). "Fluidigm Pops After IPO". TheStreet. Retrieved 2023-12-11.
  5. 1 2 "Fluidigm: 250 Million Microfluidic Valves Manufactured – and Counting". Nanotechnology Business Journal. 7 Sep 2009. Archived from the original on 2 April 2015.
  6. 1 2 "Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences – Creating a Single-Cell Technology Powerhouse". Standard BioTools Press Release. 9 January 2014.
  7. "Dvs Sciences Introduces The Cytof® 2". Standard BioTools Press Release. 4 May 2013.
  8. "Mycometrix changes name to Fluidigm". Drug Discovery Online. 4 June 2001. Retrieved 2023-12-11.
  9. Del Conte, Natali T. (20 March 2006). "Richard DeLateur and Fludigm". The San Francisco Examiner. p. 17. Retrieved 2023-12-11.
  10. "Fluidigm postpones IPO, citing market conditions". Reuters. 22 September 2008.
  11. "Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc". Standard BioTools Press Release. 4 April 2022.
  12. "New Name, New Investment, and New CEO for Fluidigm". Meddionline. 19 April 2024.
  13. "Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools" (Press release). GlobeNewswire. October 4, 2023.

Related Research Articles

<span class="mw-page-title-main">Bioinformatics</span> Computational analysis of large, complex sets of biological data

Bioinformatics is an interdisciplinary field of science that develops methods and software tools for understanding biological data, especially when the data sets are large and complex. Bioinformatics uses biology, chemistry, physics, computer science, data science, computer programming, information engineering, mathematics and statistics to analyze and interpret biological data. The process of analyzing and interpreting data can sometimes be referred to as computational biology, however this distinction between the two terms is often disputed. To some, the term computational biology refers to building and using models of biological systems.

<span class="mw-page-title-main">Microfluidics</span> Interdisciplinary science

Microfluidics refers to a system that manipulates a small amount of fluids using small channels with sizes of ten to hundreds of micrometres. It is a multidisciplinary field that involves molecular analysis, molecular biology, and microelectronics. It has practical applications in the design of systems that process low volumes of fluids to achieve multiplexing, automation, and high-throughput screening. Microfluidics emerged in the beginning of the 1980s and is used in the development of inkjet printheads, DNA chips, lab-on-a-chip technology, micro-propulsion, and micro-thermal technologies.

<span class="mw-page-title-main">Flow cytometry</span> Lab technique in biology and chemistry

Flow cytometry (FC) is a technique used to detect and measure the physical and chemical characteristics of a population of cells or particles.

A lab-on-a-chip (LOC) is a device that integrates one or several laboratory functions on a single integrated circuit of only millimeters to a few square centimeters to achieve automation and high-throughput screening. LOCs can handle extremely small fluid volumes down to less than pico-liters. Lab-on-a-chip devices are a subset of microelectromechanical systems (MEMS) devices and sometimes called "micro total analysis systems" (μTAS). LOCs may use microfluidics, the physics, manipulation and study of minute amounts of fluids. However, strictly regarded "lab-on-a-chip" indicates generally the scaling of single or multiple lab processes down to chip-format, whereas "μTAS" is dedicated to the integration of the total sequence of lab processes to perform chemical analysis.

Invitrogen is one of several brands under the Thermo Fisher Scientific corporation. The product line includes various subbrands of biotechnology products, such as machines and consumables for polymerase chain reaction, reverse transcription, cloning, culturing, stem cell production, cell therapy, regenerative medicine, immunotherapy, transfection, DNA/RNA purification, diagnostic tests, antibodies, and immunoassays.

Sigma-Aldrich is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group.

The Association of Biomolecular Resource Facilities (ABRF) is dedicated to advancing core and research biotechnology laboratories through research, communication, and education. ABRF members include over 2000 scientists representing 340 different core laboratories in 41 countries, including those in industry, government, academic and research institutions.

<span class="mw-page-title-main">Bio-MEMS</span>

Bio-MEMS is an abbreviation for biomedical microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single chips. In this definition, lab-on-a-chip devices do not strictly have biological applications, although most do or are amenable to be adapted for biological purposes. Similarly, micro total analysis systems may not have biological applications in mind, and are usually dedicated to chemical analysis. A broad definition for bio-MEMS can be used to refer to the science and technology of operating at the microscale for biological and biomedical applications, which may or may not include any electronic or mechanical functions. The interdisciplinary nature of bio-MEMS combines material sciences, clinical sciences, medicine, surgery, electrical engineering, mechanical engineering, optical engineering, chemical engineering, and biomedical engineering. Some of its major applications include genomics, proteomics, molecular diagnostics, point-of-care diagnostics, tissue engineering, single cell analysis and implantable microdevices.

<span class="mw-page-title-main">CyTOF</span>

Cytometry by time of flight, or CyTOF, is an application of mass cytometry used to quantify labeled targets on the surface and interior of single cells. CyTOF allows the quantification of multiple cellular components simultaneously using an ICP-MS detector.

<span class="mw-page-title-main">Stephen Quake</span> American scientist, inventor and entrepreneur (born 1969)

Stephen Ronald Quake is an American physicist, inventor, and entrepreneur.

Microfluidics in chemical biology is the application of microfluidics in the study of chemical biology.

<span class="mw-page-title-main">Miltenyi Biotec</span> Global biotechnology company

Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany. The company is a provider of products and services for scientists, clinical researchers, and physicians to use in their basic research, translational research, and clinical applications. These services include techniques of sample preparation, cell separation, cell sorting, flow cytometry, spatial biology, cell culture, molecular analysis, clinical applications and small animal imaging. According to Miltenyi Biotec own internal sources, the company states that it has over 3,000 employees in 28 countries and produces more than 17,000 products although this has not been independently verified.

<span class="mw-page-title-main">Single-cell analysis</span> Study of biochemical processes in an individual cell

In cell biology, single-cell analysis and subcellular analysis refer to the study of genomics, transcriptomics, proteomics, metabolomics, and cell–cell interactions at the level of an individual cell, as opposed to more conventional methods which study bulk populations of many cells.

<span class="mw-page-title-main">Mass cytometry</span> Laboratory technique

Mass cytometry is a mass spectrometry technique based on inductively coupled plasma mass spectrometry and time of flight mass spectrometry used for the determination of the properties of cells (cytometry). In this approach, antibodies are conjugated with isotopically pure elements, and these antibodies are used to label cellular proteins. Cells are nebulized and sent through an argon plasma, which ionizes the metal-conjugated antibodies. The metal signals are then analyzed by a time-of-flight mass spectrometer. The approach overcomes limitations of spectral overlap in flow cytometry by utilizing discrete isotopes as a reporter system instead of traditional fluorophores which have broad emission spectra.

<span class="mw-page-title-main">Andrew deMello</span> British chemist

Andrew James deMello is a British chemist and Professor of Biochemical Engineering at ETH Zürich.

Aclara Biosciences, Inc. was a medical technology company, focused on developing applications of microfluidics for use in laboratory testing. It was publicly traded on NASDAQ under the symbol ACLA.

<span class="mw-page-title-main">Dmitry Bandura</span> Canadian scientist

Dmitry Bandura is a Soviet-born Canadian scientist, notable for being one of the co-inventors of the Mass cytometry technology. Bandura co-founded DVS Sciences in 2004 along with Drs Vladimir Baranov, Scott D. Tanner, and Olga Ornatsky.

<span class="mw-page-title-main">Vladimir Baranov</span> Soviet-born Canadian scientist

Vladimir Baranov is a Soviet born Canadian scientist and one of the original co-inventors of Mass cytometry technology...

<span class="mw-page-title-main">Scott D. Tanner</span> Canadian scientist

Scott Tanner is a Canadian scientist, inventor, and entrepreneur. His areas of expertise include mass spectroscopy, especially inductively coupled plasma mass spectrometry (ICP-MS), and mass cytometry.

<span class="mw-page-title-main">Olga Ornatsky</span> Canadian Scientist

Olga Ornatsky is a Soviet born, Canadian scientist. Ornatsky co-founded DVS Sciences in 2004 along with Dmitry Bandura, Vladimir Baranov and Scott D. Tanner.

References